BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22001426)

  • 1. Evidence that LPS-reactive arthritis in rats depends on the glial activity and the fractalkine-TNF-α signaling in the spinal cord.
    Bressan E; Peres KC; Tonussi CR
    Neuropharmacology; 2012 Feb; 62(2):947-58. PubMed ID: 22001426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPS-induced knee-joint reactive arthritis and spinal cord glial activation were reduced after intrathecal thalidomide injection in rats.
    Bressan E; Mitkovski M; Tonussi CR
    Life Sci; 2010 Oct; 87(15-16):481-9. PubMed ID: 20837031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of TNFalpha, IL-1beta and CINC-1 for articular incapacitation, edema and cell migration in a model of LPS-induced reactive arthritis.
    Bressan E; Cunha Fde Q; Tonussi CR
    Cytokine; 2006 Oct; 36(1-2):83-9. PubMed ID: 17166735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
    Milligan ED; Zapata V; Chacur M; Schoeniger D; Biedenkapp J; O'Connor KA; Verge GM; Chapman G; Green P; Foster AC; Naeve GS; Maier SF; Watkins LR
    Eur J Neurosci; 2004 Nov; 20(9):2294-302. PubMed ID: 15525271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis.
    Xu B; Zhang WS; Yang JL; Lû N; Deng XM; Xu H; Zhang YQ
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):e158-66. PubMed ID: 20626414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures.
    Lee SM; Yune TY; Kim SJ; Kim YC; Oh YJ; Markelonis GJ; Oh TH
    J Neurochem; 2004 Nov; 91(3):568-78. PubMed ID: 15485488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline and fluorocitrate suppress spinal nociceptive signaling in intrathecal IL-1β-induced thermal hyperalgesic rats.
    Sung CS; Cherng CH; Wen ZH; Chang WK; Huang SY; Lin SL; Chan KH; Wong CS
    Glia; 2012 Dec; 60(12):2004-17. PubMed ID: 22972308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.
    Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC
    Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine.
    Milligan E; Zapata V; Schoeniger D; Chacur M; Green P; Poole S; Martin D; Maier SF; Watkins LR
    Eur J Neurosci; 2005 Dec; 22(11):2775-82. PubMed ID: 16324111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of peripheral and spinal tumor necrosis factor α in spinal cord hyperexcitability during knee joint inflammation in rats.
    König C; Zharsky M; Möller C; Schaible HG; Ebersberger A
    Arthritis Rheumatol; 2014 Mar; 66(3):599-609. PubMed ID: 24574220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cathepsin S and fractalkine contribute to chronic pain in the collagen-induced arthritis model.
    Clark AK; Grist J; Al-Kashi A; Perretti M; Malcangio M
    Arthritis Rheum; 2012 Jun; 64(6):2038-47. PubMed ID: 22213084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis.
    Sun S; Cao H; Han M; Li TT; Pan HL; Zhao ZQ; Zhang YQ
    Pain; 2007 May; 129(1-2):64-75. PubMed ID: 17123734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal tumor necrosis factor alpha neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor alpha during induction and maintenance of peripheral inflammation.
    Boettger MK; Weber K; Grossmann D; Gajda M; Bauer R; Bär KJ; Schulz S; Voss A; Geis C; Bräuer R; Schaible HG
    Arthritis Rheum; 2010 May; 62(5):1308-18. PubMed ID: 20213802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia.
    Hua XY; Svensson CI; Matsui T; Fitzsimmons B; Yaksh TL; Webb M
    Eur J Neurosci; 2005 Nov; 22(10):2431-40. PubMed ID: 16307586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for suppression of electroacupuncture on spinal glial activation and behavioral hypersensitivity in a rat model of monoarthritis.
    Sun S; Cao H; Han M; Li TT; Zhao ZQ; Zhang YQ
    Brain Res Bull; 2008 Jan; 75(1):83-93. PubMed ID: 18158100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain.
    Mika J; Rojewska E; Makuch W; Przewlocka B
    Neuroscience; 2010 Feb; 165(4):1420-8. PubMed ID: 19961904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord fractalkine (CX3CL1) signaling is critical for neuronal sensitization in experimental nonspecific, myofascial low back pain.
    Sessler K; Blechschmidt V; Hoheisel U; Mense S; Schirmer L; Treede RD
    J Neurophysiol; 2021 May; 125(5):1598-1611. PubMed ID: 33596743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal astrocyte and microglial activation contributes to rat pain-related behaviors induced by the venom of scorpion Buthus martensi Karch.
    Jiang F; Liu T; Cheng M; Pang XY; Bai ZT; Zhou JJ; Ji YH
    Eur J Pharmacol; 2009 Nov; 623(1-3):52-64. PubMed ID: 19782067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target.
    Boettger MK; Hensellek S; Richter F; Gajda M; Stöckigt R; von Banchet GS; Bräuer R; Schaible HG
    Arthritis Rheum; 2008 Aug; 58(8):2368-78. PubMed ID: 18668541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms.
    Pabreja K; Dua K; Sharma S; Padi SS; Kulkarni SK
    Eur J Pharmacol; 2011 Jul; 661(1-3):15-21. PubMed ID: 21536024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.